The Essential Elements of Local Public Health provides updates and information from NACCHO’s Environmental Health and Infectious Disease portfolios.
On August 31, FDA amended the EUAs of the Moderna and Pfizer-BioNTech vaccines to authorize bivalent formulations to be used as...
Sep 02, 2022 | Beth Hess
With a new school year beginning, this is a reminder that routine vaccines are a safe and effective way to protect children against 17...
Sep 01, 2022 | Kaye Hayes
On July 13, 2022 the Federal Drug Administration (FDA) issued an emergency use authorization (EUA) for Novavax COVID-19 Vaccine,...
Aug 25, 2022 | Amiris Roberson
Through a Virtual Learning Collaborative, local health departments identified strategies to strengthen their capacity to prioritize...
Aug 22, 2022 | Gideon Amaniel
These resources can help LHD staff understand where to begin when it comes to supporting schools in their efforts to improve indoor...
Jul 29, 2022 | Angana Roy
Join this webinar on Wednesday, August 3, 1:00-2:30 PM ET.
Jul 13, 2022 | Beth Hess
CDC's new report, COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022 concludes that the threat of AR infections is...
Jul 12, 2022 | Kimberly Nalley
Jul 08, 2022 | Victoria Thompson
NACCHO invited LHD directors and staff to provide insight into their health department’s COVID response by participating in one of two...
Jul 07, 2022 | Hitomi Abe
On August 31, FDA amended the EUAs of the Moderna and Pfizer-BioNTech vaccines to authorize bivalent formulations to be used as booster doses as least two months following previous primary or booster vaccination.
With a new school year beginning, this is a reminder that routine vaccines are a safe and effective way to protect children against 17 harmful diseases, like chickenpox and measles.
On July 13, 2022 the Federal Drug Administration (FDA) issued an emergency use authorization (EUA) for Novavax COVID-19 Vaccine, Adjuvanted for the prevention of the virus in individuals 18 years and older.
Through a Virtual Learning Collaborative, local health departments identified strategies to strengthen their capacity to prioritize Maternal and Child Health populations in emergency preparedness, response, recovery, and mitigation activities.
These resources can help LHD staff understand where to begin when it comes to supporting schools in their efforts to improve indoor air quality.
CDC's new report, COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022 concludes that the threat of AR infections is not only still present but has gotten worse in the U.S.
NACCHO invited LHD directors and staff to provide insight into their health department’s COVID response by participating in one of two hotwash sessions
Create an account or login to MyNACCHO and go to "My Subscriptions."
NACCHO, with support from the Centers for Disease Control and Prevention (CDC), released a funding opportunity for The Improving...
Feb 12, 2024 | Tori Decea
The EPA's Small Communities, Big Challenges Competition encourages local governments to demonstrate their innovative strategies, from...
Nov 16, 2023 | Anu Varma
Celebrate with us!
Oct 12, 2023 | Anu Varma
Sep 11, 2023 | Irene Halferty, Kristen Ross
Sep 08, 2023 | Irene Halferty, Kristen Ross
The Building Local Operational Capacity for COVID-19, Healthcare-Associated Infections, and Antimicrobial Resistance (BLOC COVID-19+)...
Aug 14, 2023 | Irene Halferty, Kristen Ross
This blog embodies NACCHO's mission to empower local health departments and drive positive change.
Stories from the Field provides a means for local health departments to share their experiences and demonstrate the value of public health.
The Preparedness Brief provides updates and information from NACCHO’s public health preparedness portfolio.
The NACCHO website uses cookies to offer our visitors a better browsing experience, to analyze our website traffic, and to present personalized content; cookies are small data files that are attached to your computer when you visit websites. You can read about how we use cookies by clicking on the "details" button below. If you continue to use this website, you are consenting to our use of cookies.
